|
James B. Renacci
|
house |
CVS HEALTH CORPORATION (CVS) |
CVS |
STOCK |
PURCHASE
|
March 22, 2017 |
$$15,001 - $50,000 |
April 4, 2017 |
|
Patty Murray
|
senate |
CVS Health Corporation |
CVS |
STOCK |
Purchase
|
March 16, 2017 |
$$1,001 - $15,000 |
March 21, 2017 |
|
John F Reed
|
senate |
Express Scripts Holding Company |
CVS |
STOCK |
Sale (Full)
|
March 15, 2017 |
$$1,001 - $15,000 |
March 16, 2017 |
|
James B. Renacci
|
house |
NOVARTIS A G SPONSORED ADR (SWITZERLAND) (NVS) |
NVS |
STOCK |
Purchase
|
March 14, 2017 |
$$15,001 - $50,000 |
April 4, 2017 |
|
James B. Renacci
|
house |
NOVARTIS A G SPONSORED ADR (SWITZERLAND) (NVS) |
NVS |
STOCK |
Sale
|
March 14, 2017 |
$$15,001 - $50,000 |
April 4, 2017 |
|
James B. Renacci
|
house |
CVS HEALTH CORPORATION (CVS) |
CVS |
STOCK |
PURCHASE
|
March 7, 2017 |
$$15,001 - $50,000 |
March 21, 2017 |
|
John F Reed
|
senate |
Express Scripts Holding Company |
CVS |
STOCK |
Sale (Full)
|
March 6, 2017 |
$$1,001 - $15,000 |
March 7, 2017 |
|
JOHN BOOZMAN
|
senate |
Vanguard Scottsdale Fds Srt Trm Corp |
VSSPX |
FUND |
Purchases
|
Feb. 23, 2017 |
$$1,001-$15,000 |
March 8, 2017 |
|
Sheldon Whitehouse
|
senate |
CVS Health Corporation |
CVS |
STOCK |
Sale (Partial)
|
Feb. 23, 2017 |
$$15,001 - $50,000 |
March 15, 2017 |
|
Francis Rooney
|
house |
Novartis AG Sponsored ADR |
NVS |
STOCK |
PURCHASE
|
Feb. 17, 2017 |
$$1,000-15,000 |
Feb. 17, 2017 |
|
James B. Renacci
|
house |
CVS HEALTH CORPORATION |
CVS |
STOCK |
PURCHASE
|
Feb. 8, 2017 |
$$1,001 - $15,000 |
Feb. 22, 2017 |
|
James B. Renacci
|
house |
CVS HEALTH CORPORATION (CVS) |
CVS |
STOCK |
PURCHASE
|
Feb. 2, 2017 |
$$100,001 - $250,000 |
Feb. 22, 2017 |
|
James B. Renacci
|
house |
NOVARTIS A G SPONSORED ADR (SWITZERLAND) NVNS |
NVS |
STOCK |
Purchase
|
Jan. 23, 2017 |
$$1,000 - $15,000 |
Feb. 7, 2017 |
|
Pete Sessions
|
house |
Versum Materials, Inc. (VSM) |
VSM |
STOCK |
S
|
Jan. 11, 2017 |
$$1,001 - $15,000 |
Jan. 12, 2017 |
|
Thomas MacArthur
|
house |
CVS Health Corporation (CVS) |
CVS |
STOCK |
Purchase
|
Jan. 11, 2017 |
$$100,001 - $250,000 |
Feb. 8, 2017 |
|
Thomas MacArthur
|
house |
CVS Health Corporation (CVS) |
CVS |
STOCK |
Purchase
|
Jan. 11, 2017 |
$$1,001 - $15,000 |
Feb. 8, 2017 |
|
Thomas MacArthur
|
house |
CVS Health Corporation (CVS) |
CVS |
STOCK |
Purchase
|
Jan. 11, 2017 |
$$1,001 - $15,000 |
Feb. 8, 2017 |
|
Carlos Mr Curbelo
|
house |
CVS Health Corporation (CVS) |
CVS |
STOCK |
Purchase
|
Dec. 30, 2016 |
$$1,001 - $15,000 |
Jan. 10, 2017 |
|
Richard L. Hanna
|
house |
Las Vegas Sands Corp. (LVS) |
LVS |
STOCK |
S
|
Dec. 28, 2016 |
$$15,001 - $50,000 |
Jan. 18, 2017 |
|
John Hoeven
|
senate |
ViaSat, Inc. |
VSAT |
STOCK |
Sale (Full)
|
Dec. 22, 2016 |
$$15,001 - $50,000 |
Dec. 22, 2016 |
|
Thomas J. Rooney
|
house |
CVS Health Corporation (CVS) |
CVS |
STOCK |
Purchase
|
Dec. 21, 2016 |
$$50,001 - $100,000 |
Jan. 24, 2017 |
|
Susan M Collins
|
senate |
Express Scripts Holding Company |
CVS |
STOCK |
Sale (Full)
|
Dec. 16, 2016 |
$$1,001 - $15,000 |
May 10, 2017 |
|
Susan M Collins
|
senate |
Express Scripts Holding Company |
CVS |
STOCK |
Sale (Full)
|
Dec. 16, 2016 |
$$1,001 - $15,000 |
Jan. 10, 2017 |
|
James B. Renacci
|
house |
NOVARIART S SPONSORED ADR (SWITZERLAND) (NVS) |
NVS |
STOCK |
Sale
|
Dec. 13, 2016 |
$$50,001 - $100,000 |
Dec. 20, 2016 |
|
Debbie Dingell
|
house |
Novartis ag (NVS) |
NVS |
STOCK |
Purchase
|
Dec. 5, 2016 |
$$1,001 - $15,000 |
Dec. 15, 2016 |